Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model

Published:2019-01 Issue: Volume:173 Page:27-35
ISSN:0927-7765
Container-title:Colloids and Surfaces B: Biointerfaces
language:en
Short-container-title:Colloids and Surfaces B: Biointerfaces

Author:

Lakkadwala Sushant,Singh Jagdish

Funder

National Institutes of HealthNational Institutes of Health (NIH)

Publisher

Elsevier BV

Subject

Colloid and Surface Chemistry,Physical and Theoretical Chemistry,Surfaces and Interfaces,General Medicine,Biotechnology

Reference45 articles.

1. Evaluation of human brain tumor heterogeneity using multiple T1-based MRI signal weighting approaches;Donahue;Magn. Reson. Med.,2008

2. Breast cancer metastasis to the central nervous system;Weil;Am. J. Pathol.,2005

3. Glioblastoma survival in the United States before and during the temozolomide era;Johnson;J. Neurooncol.,2012

4. Recent advances in radiation oncology;Lichter;N. Engl. J. Med.,1995

5. Nanocarriers as an emerging platform for cancer therapy;Peer;Nat. Nanotechnol.,2007

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Biomaterials Based Strategies for Neurodegeneration: Recent Advancements and Future Prospects;Current Drug Delivery;2024-10

2. Advancing glioblastoma treatment through iron metabolism: A focus on TfR1 and Ferroptosis innovations;International Journal of Biological Macromolecules;2024-10

3. Charge-switchable cell-penetrating peptides for rerouting nanoparticles to glioblastoma treatment;Colloids and Surfaces B: Biointerfaces;2024-09

4. Nanomedicine-induced programmed cell death in cancer therapy: mechanisms and perspectives;Cell Death Discovery;2024-08-29

5. Combination chemotherapy via poloxamer 188 surface-modified PLGA nanoparticles that traverse the blood–brain–barrier in a glioblastoma model;Scientific Reports;2024-08-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3